Pfizer
Jiayi Hao is a seasoned professional in the biopharmaceutical sector, currently serving as Senior Director for both Strategic Partnerships and Portfolio Management at Pfizer Ignite since November 2022. In this role, Jiayi Hao helps biotech partners leverage Pfizer's extensive resources and expertise to enhance innovation throughout the development lifecycle. Previously, Jiayi Hao held the position of VP of Business Operations and Strategy at PathAI from 2021 to 2022, focusing on strategic marketing and sales operations in an AI-driven pathology startup. At Flatiron Health from 2018 to 2021, Jiayi Hao led business development and commercial strategy, collaborating with top biopharma companies on innovative projects utilizing real-world oncology datasets. Prior experiences include an Engagement Manager role at McKinsey & Company, where Jiayi Hao managed global teams advising biopharma on R&D and commercial strategies, along with positions at Lux Capital and IMS Consulting Group, which provided substantial experience in pricing, market access, and therapeutic areas. Jiayi Hao holds an MBA from Columbia Business School and an AB in Economics from Dartmouth College.
This person is not in any teams
Pfizer
605 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.